KOR

e-Article

Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial
Document Type
Article
Source
In The Lancet Oncology November 2020 21(11):1443-1454
Subject
Primary Research
Articles
Language
ISSN
1470-2045